| Kelly Marie Miller, FNP-C | |
|
1420 S Business 61 Ste Def, Bowling Green, MO 63334-5230 | |
| (573) 324-5562 | |
| Not Available |
| Full Name | Kelly Marie Miller |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 1420 S Business 61 Ste Def, Bowling Green, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235691619 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2019010659 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Health At Home Home Health-st Louis | Saint louis, MO | Home health agency |
| Ssm St Joseph Hospital West | Lake saint louis, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ssm Medical Group Inc | 6608776299 | 491 |
| Ssm Select Rehab St Louis Llc | 2567510449 | 130 |
News Archive
Meibomian gland dysfunction is the leading cause of dry eye disease, which affects tens of millions of Americans. However, there is no FDA-approved treatment for MGD. Researchers from the Schepens Eye Research Institute/Massachusetts Eye and Ear and Harvard Medical School have just identified a potential therapy.
Three unique projects focused on improving global health won the National Institutes of Health's Design by Biomedical Undergraduate Teams (DEBUT) Challenge. The winners showed exemplary initiative in designing tools for a less expensive, portable device to monitor HIV treatment, a new surgical clamp to treat drooping eyelids, and a low-cost patient monitor.
Scientists from A*STAR's Singapore Immunology Network have discovered a new defense mechanism that the immune system utilises to combat infections. The team's discovery of how a novel protein unexpectedly activates an immune response shows how this mechanism can also be used to get rid of tumour cells.
Allied Healthcare Group (ASX: AHZ) has announced an update on the progress of Coridon, its investment company founded by Professor Ian Frazer and working on developing the next generation of vaccines. Included in these activities, Cordon has entered into a license agreement with Nature Technology Corporation (NTC) and has contracted VGXI Inc. in the US for production of clinical material for the Phase I study scheduled to begin later this year.
› Verified 6 days ago
| Entity Name | Ssm Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700966207 PECOS PAC ID: 6608776299 Enrollment ID: O20040729001034 |
News Archive
Meibomian gland dysfunction is the leading cause of dry eye disease, which affects tens of millions of Americans. However, there is no FDA-approved treatment for MGD. Researchers from the Schepens Eye Research Institute/Massachusetts Eye and Ear and Harvard Medical School have just identified a potential therapy.
Three unique projects focused on improving global health won the National Institutes of Health's Design by Biomedical Undergraduate Teams (DEBUT) Challenge. The winners showed exemplary initiative in designing tools for a less expensive, portable device to monitor HIV treatment, a new surgical clamp to treat drooping eyelids, and a low-cost patient monitor.
Scientists from A*STAR's Singapore Immunology Network have discovered a new defense mechanism that the immune system utilises to combat infections. The team's discovery of how a novel protein unexpectedly activates an immune response shows how this mechanism can also be used to get rid of tumour cells.
Allied Healthcare Group (ASX: AHZ) has announced an update on the progress of Coridon, its investment company founded by Professor Ian Frazer and working on developing the next generation of vaccines. Included in these activities, Cordon has entered into a license agreement with Nature Technology Corporation (NTC) and has contracted VGXI Inc. in the US for production of clinical material for the Phase I study scheduled to begin later this year.
› Verified 6 days ago
| Entity Name | Pike County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124030424 PECOS PAC ID: 8123015518 Enrollment ID: O20050407000376 |
News Archive
Meibomian gland dysfunction is the leading cause of dry eye disease, which affects tens of millions of Americans. However, there is no FDA-approved treatment for MGD. Researchers from the Schepens Eye Research Institute/Massachusetts Eye and Ear and Harvard Medical School have just identified a potential therapy.
Three unique projects focused on improving global health won the National Institutes of Health's Design by Biomedical Undergraduate Teams (DEBUT) Challenge. The winners showed exemplary initiative in designing tools for a less expensive, portable device to monitor HIV treatment, a new surgical clamp to treat drooping eyelids, and a low-cost patient monitor.
Scientists from A*STAR's Singapore Immunology Network have discovered a new defense mechanism that the immune system utilises to combat infections. The team's discovery of how a novel protein unexpectedly activates an immune response shows how this mechanism can also be used to get rid of tumour cells.
Allied Healthcare Group (ASX: AHZ) has announced an update on the progress of Coridon, its investment company founded by Professor Ian Frazer and working on developing the next generation of vaccines. Included in these activities, Cordon has entered into a license agreement with Nature Technology Corporation (NTC) and has contracted VGXI Inc. in the US for production of clinical material for the Phase I study scheduled to begin later this year.
› Verified 6 days ago
| Entity Name | Pike County Memorial Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1205837218 PECOS PAC ID: 8123015518 Enrollment ID: O20061104000299 |
News Archive
Meibomian gland dysfunction is the leading cause of dry eye disease, which affects tens of millions of Americans. However, there is no FDA-approved treatment for MGD. Researchers from the Schepens Eye Research Institute/Massachusetts Eye and Ear and Harvard Medical School have just identified a potential therapy.
Three unique projects focused on improving global health won the National Institutes of Health's Design by Biomedical Undergraduate Teams (DEBUT) Challenge. The winners showed exemplary initiative in designing tools for a less expensive, portable device to monitor HIV treatment, a new surgical clamp to treat drooping eyelids, and a low-cost patient monitor.
Scientists from A*STAR's Singapore Immunology Network have discovered a new defense mechanism that the immune system utilises to combat infections. The team's discovery of how a novel protein unexpectedly activates an immune response shows how this mechanism can also be used to get rid of tumour cells.
Allied Healthcare Group (ASX: AHZ) has announced an update on the progress of Coridon, its investment company founded by Professor Ian Frazer and working on developing the next generation of vaccines. Included in these activities, Cordon has entered into a license agreement with Nature Technology Corporation (NTC) and has contracted VGXI Inc. in the US for production of clinical material for the Phase I study scheduled to begin later this year.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelly Marie Miller, FNP-C 2305 Georgia St, Louisiana, MO 63353-2559 Ph: (573) 754-4584 | Kelly Marie Miller, FNP-C 1420 S Business 61 Ste Def, Bowling Green, MO 63334-5230 Ph: (573) 324-5562 |
News Archive
Meibomian gland dysfunction is the leading cause of dry eye disease, which affects tens of millions of Americans. However, there is no FDA-approved treatment for MGD. Researchers from the Schepens Eye Research Institute/Massachusetts Eye and Ear and Harvard Medical School have just identified a potential therapy.
Three unique projects focused on improving global health won the National Institutes of Health's Design by Biomedical Undergraduate Teams (DEBUT) Challenge. The winners showed exemplary initiative in designing tools for a less expensive, portable device to monitor HIV treatment, a new surgical clamp to treat drooping eyelids, and a low-cost patient monitor.
Scientists from A*STAR's Singapore Immunology Network have discovered a new defense mechanism that the immune system utilises to combat infections. The team's discovery of how a novel protein unexpectedly activates an immune response shows how this mechanism can also be used to get rid of tumour cells.
Allied Healthcare Group (ASX: AHZ) has announced an update on the progress of Coridon, its investment company founded by Professor Ian Frazer and working on developing the next generation of vaccines. Included in these activities, Cordon has entered into a license agreement with Nature Technology Corporation (NTC) and has contracted VGXI Inc. in the US for production of clinical material for the Phase I study scheduled to begin later this year.
› Verified 6 days ago
Dr. Donald Albert Miller, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Town Center Dr, Bowling Green, MO 63334 Phone: 573-324-2241 Fax: 573-324-9854 | |
Dr. Dorothy E Swingle, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 710 S Business 61, Bowling Green, MO 63334 Phone: 573-324-2063 Fax: 573-324-2167 | |
Dr. Cole Joseph Scherder, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Town Center Dr, Bowling Green, MO 63334 Phone: 573-324-2241 Fax: 573-324-8964 | |
Brandon C.w. Brown, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Town Center Dr, Bowling Green, MO 63334 Phone: 573-324-2241 Fax: 573-324-2617 | |
Dr. Jennifer Imara Hayes-bethel, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 8 Town Center Dr, Bowling Green, MO 63334 Phone: 573-324-2241 Fax: 573-324-2617 | |
Dr. Michael H. Whitlock, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1420 S Business 61 Ste Def, Bowling Green, MO 63334 Phone: 573-324-5562 |